Scarsdale Nightingale Close Newbold Chesterfield S41 7PF Tel.: 01246 514048 Date: 5 June 2018 FREEDOM OF INFORMATION DECISION NOTICE Dear Sir / Madam, FOI Reference Number: 870 I refer to your email of 17 May 2018 requesting information in respect of prescribing QIPP and rebate schemes. I can confirm on behalf of Southern Derbyshire CCGs, and in accordance with S.1 (1) of the Freedom of Information Act 2000 (FOIA) that we do hold some of the information that you have requested. A response to each element of your request is detailed below: Our response: A- For the Financial Year 2017/2018 Could you please provide me with the details of any prescribing rebate schemes and QIPP/efficiency saving prescribing schemes active within your CCG during the financial year 2017/18? Please answer the questions below: 1. Primary Care Prescribing Rebate Schemes 2017/18 Name of Scheme Drug(s) covered Companies involved in the scheme Aproderm Barrier Cream Aproderm Barrier Cream 100g & Fontus Health Ltd 30g Aquamax Cream Aquamax Cream 100g & 500g Intrapharm Laboratories Ltd Sevodyne Sevodyne Aspire Pharma Carbocisteine Sachets Firmagon (degarelix) Carbocisteine 750mg/10ml sugar free oral solution in sachet Firmagon Initiation 2 x 120mg Firmagon Maintenance 1 x 80mg Intrapharm Laboratories Ltd Ferring Pharmaceuticals (UK)
Fencino (Fentanyl Fentanyl Transdermal matrix DB Ashbourne Ltd Transdermal matrix patch) patches (Fencino) Mezolar Matrix Mezolar Matrix 12mcg/hr, Sandoz 25mcg/hr, 37.5mcg/hr, 50mcg/hr, 75mcg/hr, 100mcg/hr Luventa XL Capsules Luventa XL capsules 8mg, Fontus Health Ltd 16mg, 24mg Zoladex (Goserelin) Zoladex (Goserelin) 3.6mg, or AstraZeneca UK Ltd 10.8mg Apidra Apidra (Insulin Glulisine) Sanofi Apidra 5x3ml Cartridge Optipen Apidra Solostar 5 Prefilled Pens Apidra Vials 1x10ml Insupen Insulin Needles Insupen 4mm/33G Spirit Healthcare Limited Prostap DCS Lupin Oral Contraceptive Medicom Healthcare Dry Eye PCRS Leuprorelin acetate depot injection 3.75mg (Prostap SR DCS) / Leuprorelin acetate depot injection 11.25mg (Prostap 3 DCS) Aidulan 0.075/0.02mg, 0.075/0.03mg, Yiznell 3/0.03mg, Feanolla 0.075mg, Munalea 0.15/0.02mg, 0.15/0.03mg and Maexeni 0.15/0.03mg Lumecare Carbomer 0.2% Lumecare Singles Carmellose 0.5% Lumecare Advance Carmellose 0.5% Lumecare Singles Hypromellose 0.3% Lumecare Hypromellose 0.3% Evolve Carmellose 0.5% Evolve Hypromellose 0.3% Evolve HA 0.2% Takeda UK Ltd NeoNavitas Ltd Medicom Healthcare LTD Glucophage SR Glucophage SR Merck Serono Ltd Insuman OneTouch Select Plus ABTARD (Oxycodone Hydrochloride Prolonged Release Tablets) Sanofi Insuman Products Insuman Comb 15 cartridge 5x3ml Insuman Comb 25 Solostar 5x3ml, Cartridge 5x3ml, Vial 5ml Insuman Basal Solostar 5x3ml, Cartridge 5x3ml, Vial 5ml Insuman Rapid Cartridge 5x3ml OneTouch Select Plus Test Strips ABTARD Sanofi Johnson & Johnson Medical Limited Ethypharm UK Ltd Mintreleq XL (Quetiapine) Mintreleq XL Aristo Pharma Ltd Zaluron XL Tablets Zaluron XL prolonged release tablets 50mg, 150mg, 200mg, 300mg, 400mg Fontus Health Ltd
Reletrans (Buprenorphine) 7 Day transdermal patches AirFluSal Forspiro Stocare Stoma Accessories TRUEresult blood glucose testing strips WaveSense JAZZ Clexane (enoxaparin) Symbicort Turbohaler (budesonide/formoterol) Reletrans transdermal patches 5mcg/h, 10mcg/h, 15mcg/h, 20mcg/h AirFluSal Forspiro 50mcg/500mcg Stocare Adhesive Remover Spray Aerosol 50ml Stocare Medical Adhesive Remover Wipes 30 Stocare Protect Barrier Spray Aerosol 50ml TRUEresult blood glucose testing strips WaveSense JAZZ blood glucose testing strips Clexane, 20mg, 40mg, 60mg, 80mg, 100mg, 120mg, 150mg Clexane MDV 1x3ml Symbicort Turbohaler 100/6, 200/6, 400/12 Sandoz Sandoz Rhodes Pharma Ltd Nipro Diagnostics (UK) Ltd Agamatrix Europe Ltd Sanofi AstraZeneca 2. What was the total income for the CCG from rebates during 2017/18? We do not currently hold this data for 2017/18. We would expect this information to be available from July 2018. 3. QIPP Prescribing Schemes 17/18 Please see attached. B - For the Financial Year 2018/2019 Could you please provide me with the details of any prescribing rebate schemes and QIPP/efficiency saving prescribing schemes active within your CCG for the current financial year 2018-19 (as they currently stand)? 1 Current Primary Care Prescribing Rebate Schemes 18/19 Please see our Derbyshire Medicines Management website at the following location: http://www.derbyshiremedicinesmanagement.nhs.uk/assets/non_clinical_guidelines/misc/derbyshire_r ebate_scheme_process_with_presqipp.pdf 2 Current QIPP Prescribing Schemes 18/19 Name of Scheme Drug(s) covered Rebates See Question 1 Optimise Rx Patent Expiries and Branded Price Reductions All British National Formulary (BNF)
Secondary Care High Cost Drugs Repeat Prescribing Initiatives Gluten Free Policy Self Care Policy Switches, stopping drugs and medication reviews Nutrition Project Syringe Driver Service Review Pharmacy First Service Review All new biologic biosimilars. Gluten Free Products https://www.england.nhs.uk/publication/conditionsfor-which-over-the-counter-items-should-notroutinely-be-prescribed-in-primary-care-guidancefor-ccgs/ Oral Nutritional Supplements Medicines included in syringe drivers Clotrimazole 1% cream, Miconazole cream Chloramphenicol drops and ointment Ispaghula husk, senna tablets, lactulose solution, glycerol suppositories Paracetamol suspension and tablets, ibuprofen syrup and tablets Oral Rehydration Salts Anusol ointment and suppositories, Anusol Plus HC ointment and suppositories Chlorphenamine tablets and solution, Cetirizine tablets and solution, loratidine tablets and solution, beclomethasone nasal spray, sodium cromoglycate eye drops Dimethicone lotion, malathion aqueous Hydrocortisone cream, crotamiton cream Mebendazole tablet Clotrimazole 2% cream, pessary, combi, fluconazole capsule 3. What is the current year 18/19 CCG QIPP/efficiency savings plan target? QIPP savings target for High Cost Drugs for Southern Derbyshire CCG: 972,358. 4. What is the value of the prescribing element for the current year 18/19 CCG QIPP/efficiency savings plan target? We do not hold this information as the final Derbyshire prescribing figure is currently still to be agreed. I hope that this answers your queries with the information we currently hold, but if I can be of any further assistance please do not hesitate to contact me. If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of receipt of the response to your original letter and should be addressed to: NHS Derbyshire CCGs FOI Team
Scarsdale Nightingale Close Newbold Chesterfield S41 7PF Or: Derbysccg.foi@nhs.net If you are not content with the outcome of your complaint, you may apply directly to the Information Commissioner for a decision. Generally, the ICO cannot make a decision unless you have exhausted the complaints procedure provided by Derbyshire CCGs. The Information Commissioner can be contacted at: Information Commissioners Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF, telephone 0303 123 1113, email casework@ico.org.uk. Yours faithfully, Kathryn Jacklin FOI Officer Southern Derbyshire CCG On behalf of NHS Southern Derbyshire CCG NHS North Derbyshire CCG NHS Hardwick CCG NHS Erewash CCG All information we have provided is subject to the provisions of the Re-use of Public Sector Information Regulations 2015. Accordingly, if the information has been made available for re-use under the Open Government Licence (OGL) a request to reuse is not required, but the licence conditions must be met. You must not re-use any previously unreleased information without having the consent from NHS Erewash CCG, NHS Hardwick CCG and NHS North Derbyshire CCG. Should you wish to re-use previously unreleased information then you must make your request in writing (email will suffice) to the FOI Lead via Derbysccg.foi@nhs.net. All requests for re-use will be responded to within 20 working days of receipt.